OncoDaily Pulse

Aug 30, 2025, 18:42

Raya Saab: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

The congress is free to attend.
Register via the link.

Co-Chair of VIRO

Images Name

Rana McKay
Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center

As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on
“Future Directions: Emerging Agents and Combinations.”

She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Raya Saab

Dr. Raya Saab is the Chief of Pediatric Oncology and a Professor at Stanford University School of Medicine.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Saab will participate in the panel discussion titled “Challenges and Opportunities of Treating Renal Tumors in Children and Young Adults.” The discussion will explore:

Unique clinical and biological characteristics of renal tumors in pediatric and young adult populations.
Diagnostic and therapeutic challenges in managing these patients.
Innovative treatment approaches and investigational therapies tailored for younger patients.
Strategies to improve outcomes and support long-term survivorship in this vulnerable group.

Leveraging her extensive clinical experience and academic leadership, Dr. Saab emphasizes multidisciplinary collaboration and research-driven care to transform the treatment landscape and enhance the lives of children and young adults with renal tumors.

Global Voices in Renal Oncology (VIRO) 2025